145
RISHTON, G. M. Nonleadlikeness and leadlikeness in biochemical screening.
Drug Discovery Today, v. 8, n. 2, p. 86-96, 2003.
ROBERTS II, L. J. e MORROW, J. D. Analgésico-antipiréticos, agentes
antiinflamatórios e fármacos utilizados no tratamento da gota.
In:
Hardman, J.
G. e Limbird, L. E. (eds.) As bases farmacológicas da terapêutica. McGraw-
Hill, Rio de Janeiro, 2003, Cap. 27, p. 517-550.
RODRIGUES, C. R.; VELOSO, M.P.; VERLI, H.
et al.
Selective PGHS-2
inhibitors: a rational approach for treatment of the inflammation. Current
Medicinal Chemistry
,
v. 9, n. 8, p. 849-867,2002.
ROSENFELD, R; VAJDA, S. e DELISI, C. Flexible docking and design. Annual
Reviews of Biophysics Biomolecular Structure, v. 24, p. 677, 1995.
SANDERS-BUSH, E. & MAYER, S. E.; Agonistas e antagonistas dos receptors
da 5-hidroxitriptamina (serotonina).
In:
HARDMAN, J. G. e LIMBIRD, L. E.
(eds.) Goodman & Gilman As bases farmacológicas da terapêutica. 10
a
ed,
McGrawHill, RJ, p 205-220, 2003.
SAVAGE, B., CATTANEO, M., RUGGERI, Z. M. Mechanisms of platelet
aggregation. Current Opinion in Hematololgy, v. 8, n. 5, p. 270-276, 2001.
SCHWAB, 2003.
SETTI, E. L. e MICETICH, R. Modern drug design and lead discovery: an
overview. Current Medicinal Chemistry, v. 3, n. 5, p. 317-324, 1996.
SHAMBUREK, R. D. e SHUBERT, M. L. Pharmacology of gastric acid
inhibition. Baillière's Clinical Gastroenterology, v. 7, n. 1, p. 23-54, 1993.
SHENG, C. Q.; ZHANG, W. N.; JI, H. T
et al.
Synthesis and antifungal activity of
1-(1,2,4-triazolyl-1H-1-yl)-2-(2,4-diflurophenyl)-3-(4-substituted benzyl-1-